ReachMD
Be part of the knowledge.™Global Oncology Academy
The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
Episodes 1-6 of 6
Keeping Pace in Hematologic Malignancies: 2023
Contextualizing the Evidence: Newly Diagnosed AML in Difficult-to-Treat SubtypesCME/CEKeeping Pace in Hematologic Malignancies: 2023
Contextualizing the Evidence: Newly Diagnosed AML in Difficult-to-Treat SubtypesKeeping Pace in Lung Cancer
Personalizing Treatment in NSCLC: Early-Stage Disease (Stage I-IIIa)CME/CEKeeping Pace in Lung Cancer
Personalizing Treatment in NSCLC: Early-Stage Disease (Stage I-IIIa)Keeping Pace in Lung Cancer: Personalizing Treatment in NSCLC: Locally Advanced Disease (Stage IIIB/C)
CME/CEKeeping Pace in Lung Cancer: Personalizing Treatment in NSCLC: Locally Advanced Disease (Stage IIIB/C)
Secondary Hyperparathyroidism: A Hidden Danger in Chronic Kidney Disease
CME/CESecondary Hyperparathyroidism: A Hidden Danger in Chronic Kidney Disease
Advancing Global Care with Emerging BTKi in Relapsed/Refractory CLL: Connecting Hematology Leaders to Worldwide Learners
CME/CEAdvancing Global Care with Emerging BTKi in Relapsed/Refractory CLL: Connecting Hematology Leaders to Worldwide Learners
Innovations in the Treatment of Locally Advanced Squamous Cell Carcinoma of Head and Neck: Enhancing Antitumor Activity Through Inhibitor of Apoptosis Protein Antagonism
CME/CEInnovations in the Treatment of Locally Advanced Squamous Cell Carcinoma of Head and Neck: Enhancing Antitumor Activity Through Inhibitor of Apoptosis Protein Antagonism
